Amkay Products IPO Date, Review, Price, Allotment Details

The Amkay Products IPO is scheduled to commence on April 30 and conclude on May 3. It aims to raise ₹12.61 crores through the issuance. Amkay Products Limited specializes in the manufacturing, assembly, and marketing of a diverse range of medical devices, disposables, and healthcare products such as Face Masks, Alcohol Swabs, Lancet Needles, Nebulizers, Pulse Oximeters, and surgeon caps.

These products find widespread usage in healthcare centers, hospitals, clinics, and nursing homes across India. Additionally, the company is involved in the branding and marketing of items like Diapers, Plastic Gloves, and Suction Machines.

Established in 2008, the company initially operated from a modest manufacturing unit in Vasai, Mumbai, covering 980 sq. feet. Over the years, it expanded its product range and operations, shifting to larger manufacturing facilities. In 2012, Amkay Products acquired a manufacturing unit in Acchad Industrial Area, Thane, spanning approximately 20,000 square feet, where it currently manufactures and supplies various medical products.

Subsequently, in 2014, the company rented a warehouse in the same industrial area for storage purposes, and in 2016, it purchased another manufacturing unit spanning around 6000 square feet, also in Acchad Industrial Area, Thane, where it currently manufactures bio bags.

Amkay Products boasts a product portfolio comprising over 30 items, including Respiratory Disease Related Medical Devices, Surgical Disposables, Home Healthcare Products, and other Healthcare Products. Presently, the company manufactures more than 20 products while also engaging in branding and trading of over 10 products.

In terms of financial performance, the company’s revenue from manufacturing operations stood at Rs. 1836.91 lakhs, Rs. 2224.59 lakhs, Rs. 2255.89 lakhs, and Rs. 3020.24 lakhs for fiscal years 2021, 2022, 2023, and the period ending December 31, 2023, respectively. Revenue from branding and trading operations during the same periods was Rs. 437.71 Lakhs, Rs. 561.83 lakhs, 1394.48 lakhs, and Rs. 1049.71 lakhs, respectively.

**Amkay Products IPO Details:**

– **IPO Dates:** The IPO is scheduled to open on April 30, 2024, and close on May 3, 2024.
– **Issue Size:** Approximately ₹12.61 Crores, with 2,292,000 Equity Shares.
– **Face Value:** ₹10 Per Equity Share.
– **Price Band:** Fixed at ₹52 to ₹55 Per Equity Share.
– **IPO Listing:** BSE SME.
– **Retail Quota:** 35% of the net offer.
– **QIB Quota:** 50% of the net offer.
– **NII Quota:** 15% of the net offer.

**Company Profile:**

Amkay Products Limited specializes in the manufacture, assembly, and marketing of a wide range of medical devices, disposables, and healthcare products. Their portfolio includes items like Face Masks, Alcohol Swabs, Lancet Needles, Nebulizers, Pulse Oximeters, Surgeon Caps, among others. They cater to healthcare centers, hospitals, clinics, and nursing homes across India.

The company commenced operations in 2008 with the manufacturing and supply of one product. Over time, they expanded their portfolio and shifted to larger manufacturing units. Presently, they operate from manufacturing units in Acchad Industrial Area, Thane, where they manufacture and supply various medical products.

**Objectives of the Issue:**

1. Funding Capital Expenditure towards installation of additional Machinery.
2. Meeting working capital requirements.
3. General Corporate Purposes.

**Financial Highlights:**

– Revenue for fiscal years 2021, 2022, and 2023 were ₹40.72 crores, ₹36.79 crores, and ₹28.25 crores respectively.
– Profit After Tax (PAT) for the same periods were ₹3.13 crores, ₹1.47 crores, and ₹1.51 crores respectively.
– As of December 2023, revenue stood at ₹23.86 crores with a PAT of ₹2.15 crores.

**Valuation (FY2023):**

– Earnings Per Share (EPS): ₹2.37 per Equity Share.
– Return on Net Worth (RoNW): 19.57%.
– Net Asset Value (NAV): ₹12.13 per Equity Share.

**Peer Group:**

– Hemant Surgical Industries Limited
– QMS Medical Allied Services Limited

**Promoters:**

– Kashyap Pravin Mody
– Hemanshu Kantilal Batavia

Investors can apply for the Amkay Products IPO through ASBA available in their bank accounts or via IPO forms downloadable from the BSE website. It’s essential to conduct thorough research and consider financial metrics and market dynamics before making investment decisions.

Profit Must is being built by a passionate team with in-depth understanding of the IPO sector and stock market. The team does their own research and publishes articles on Profitmust.com based on their findings.

error: Content is protected !!